Bombay High Court Reprimands FDA Over Arbitrary License Cancellations

The Bombay High Court recently issued a sharp reprimand to Food and Drug Administration officials for the arbitrary suspension and cancellation of operating licenses. The judicial bench scrutinized the regulatory authority’s rigid approach during inspections at the Mumbai Cricket Association stadium and the pharmaceutical company Cipla Pharma & Life Sciences. Following this strict judicial oversight, the regulatory body formally withdrew its revocation orders, allowing the affected food and drug entities to resume their regular commercial operations immediately.

The legal friction began after food safety officers and drug regulators conducted routine inspections that resulted in the sudden shutdown of dining venues and a carry and forwarding unit in Pune. Officials cited minor procedural compliance irregularities, which business owners argued were unreasonable and disproportionate grounds for immediate closure. The court observed that administrative agencies should prioritize corrective compliance notices over blunt shutdown tactics, emphasizing that statutory powers must be exercised with proper discretion and fairness to ensure minimal disruption to the supply chain.

This ruling sets a significant precedent by curbing administrative high-handedness and reinforcing the need for due process in regulatory enforcement across Maharashtra. The court suggested that commercial entities maintain active digital channels for hygiene feedback, while officials are now expected to adopt more constructive monitoring systems. This case serves as a vital reference for pharmaceutical and hospitality firms, ensuring that health safety enforcement remains accountable to judicial standards and rational decision-making protocols.